- Filed
- May 6, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · May 3, 2021 | 141.92M sh |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $140.3M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $125M |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $268.6M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $281.5M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $568.4M |
| Current Assets | Q1 2021 · Dec 31, 2020 | $522M |
| Total Assets | Q1 2021 · Mar 31, 2021 | $2.17B |
| Total Assets | Q1 2021 · Dec 31, 2020 | $2.14B |
| Shares Diluted | Q1 2021 · Mar 31, 2020 | 141.43M sh |
| Capex | Q1 2021 · Mar 31, 2020 | $5.6M |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | −$72.5M |
| Stockholders Equity restated | Q1 2021 · Mar 31, 2020 | $213.4M |
| Stockholders Equity restated | Q1 2021 · Dec 31, 2019 | $253.4M |
| Eps Diluted | Q1 2021 · Mar 31, 2020 | −$0.11 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | −$0.11 |
| Sga Expense | Q1 2021 · Mar 31, 2020 | $86.5M |
| Net Income | Q1 2021 · Mar 31, 2020 | −$15.1M |
| Gross Profit | Q1 2021 · Mar 31, 2020 | $114.8M |
| Cost Of Revenue | Q1 2021 · Mar 31, 2020 | $214.1M |
| Revenue | Q1 2021 · Mar 31, 2020 | $328.9M |